Bain Capital Public Equity Management Ii, LLC Omeros Corp Transaction History

Bain Capital Public Equity Management Ii, LLC

$1.99 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$5.67 - $8.54 $2.27 Million - $3.42 Million	-400,072 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$13.4 - $16.3 $344,286 - $418,795	-25,693 Reduced 6.03%	400,072 $5.52 Million
Q2 2021 Aug 16, 2021	SELL	$14.81 - $19.13 $3.92 Million - $5.06 Million	-264,550 Reduced 38.32%	425,765 $6.32 Million
Q1 2021 May 17, 2021	BUY	$14.52 - $23.53 $10 Million - $16.2 Million	690,315 New	690,315 $12.3 Million

Others Institutions Holding OMER

# of Institutions

120

Shares Held

25.6M

Call Options Held

228K

Put Options Held

630K

Ingalls & Snyder LLC New York, NY

4.54M
Shares

$55.2 Million
0.7% of portfolio
Black Rock Inc. New York, NY

4.1M
Shares

$49.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.26M
Shares

$39.6 Million
0.0% of portfolio
Stifel Financial Corp St. Louis, MO

1.9M
Shares

$23.1 Million
0.01% of portfolio
D. E. Shaw & Co., Inc. New York, NY

1.61M
Shares

$19.5 Million
0.01% of portfolio

View Full List

About OMEROS CORP

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $762M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

More about OMER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bain Capital Public Equity Management Ii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bain Capital Public Equity Management Ii, LLC with notifications on news.

Account